Skip to main content
Top
Published in: Annals of Surgical Oncology 7/2014

01-07-2014 | Bone and Soft Tissue Sarcomas

Patterns of Recurrence in Retroperitoneal Liposarcomas: Reflecting Surgical Approach or Tumor Biology?

Author: Dirk C. Strauss, FCS, MMed, FRCS

Published in: Annals of Surgical Oncology | Issue 7/2014

Login to get access

Excerpt

Complete surgical resection remains the mainstay of curative treatment for retroperitoneal sarcomas (RPS) and provides the only hope for long-term survival. Unfortunately, the major mode of failure leading to poor outcome for retroperitoneal liposarcoma is intra-abdominal locoregional recurrence. The cause for the high rate of local recurrence following resection of retroperitoneal liposarcomas in contrast to limb sarcoma is customarily attributed to the specific anatomical site, containing vital neural and vascular structures, axial skeleton, and visceral organs limiting the ability to perform a wide resection. In addition, inherent tumor biology of liposarcomas has to be considered. The biological behavior of retroperitoneal liposarcomas are unpredictable. Clinically, some well-differentiated (WD) RPS behave in an indolent fashion over many years and never develop a dedifferentiated (DD) component. Other DD RPS develop de novo without a documented WD component. Some WD RPS can recur with a mainly DD component and vice versa. Although WD and DD RPS have a common genetic feature associated with genomic amplification which include amplification in 12q13–15 resulting in MDM2 and CDK4 overexpression, the specific genetic and molecular events leading to the unpredictable behavior is still not clear.1
Literature
1.
go back to reference Dei Tos AP, Doglioni C, Piccinin S, et al. (2000) Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol. 190(5):531–6.PubMedCrossRef Dei Tos AP, Doglioni C, Piccinin S, et al. (2000) Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol. 190(5):531–6.PubMedCrossRef
2.
go back to reference Gronchi A, Pollock RE. Quality of local treatment or biology of the tumor: which are the trump cards for loco-regional control of retroperitoneal sarcoma? Ann Surg Oncol. 2013;20(7):2111–3.PubMedCrossRef Gronchi A, Pollock RE. Quality of local treatment or biology of the tumor: which are the trump cards for loco-regional control of retroperitoneal sarcoma? Ann Surg Oncol. 2013;20(7):2111–3.PubMedCrossRef
3.
go back to reference Raut CP, Swallow CJ. Are radical compartmental resections for retroperitoneal sarcomas justified? Ann Surg Oncol. 2010;17(6):1481–4.PubMedCrossRef Raut CP, Swallow CJ. Are radical compartmental resections for retroperitoneal sarcomas justified? Ann Surg Oncol. 2010;17(6):1481–4.PubMedCrossRef
4.
go back to reference Tseng W, Madewell J, Wei W, Somaiah N, et al. Locoregional disease patterns in well differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? ASO-2014-02-0180. doi:10.1245/s10434-014-3643-4. Tseng W, Madewell J, Wei W, Somaiah N, et al. Locoregional disease patterns in well differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? ASO-2014-02-0180. doi:10.​1245/​s10434-014-3643-4.
5.
go back to reference Anaya DA, Lahat G, Liu J, et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg. 2009;249(1):137–42.PubMedCrossRef Anaya DA, Lahat G, Liu J, et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg. 2009;249(1):137–42.PubMedCrossRef
6.
go back to reference Gronchi A, Lo Vullo S, Fiore M, et al. (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 27(1):24–30.PubMedCrossRef Gronchi A, Lo Vullo S, Fiore M, et al. (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 27(1):24–30.PubMedCrossRef
7.
go back to reference Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31–7.PubMedCrossRef Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31–7.PubMedCrossRef
8.
go back to reference Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19(9):2981–91.PubMedCrossRef Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19(9):2981–91.PubMedCrossRef
9.
go back to reference Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol. 2012;23(4):1067–73.PubMedCrossRef Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol. 2012;23(4):1067–73.PubMedCrossRef
10.
go back to reference Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17(6):1507–14.PubMedCrossRef Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17(6):1507–14.PubMedCrossRef
11.
go back to reference Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13(10):1045–54.PubMedCrossRef Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13(10):1045–54.PubMedCrossRef
12.
go back to reference Gerrand CH, Wunder JS, Kandel RA, et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br. 2001;83:1149–1155.PubMedCrossRef Gerrand CH, Wunder JS, Kandel RA, et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br. 2001;83:1149–1155.PubMedCrossRef
13.
go back to reference Gutierrez JC, Perez EA, Moffat FL, et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg. 2007;245(6):952–8.PubMedCentralPubMedCrossRef Gutierrez JC, Perez EA, Moffat FL, et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg. 2007;245(6):952–8.PubMedCentralPubMedCrossRef
14.
go back to reference van Dalen T, Hennipman A, Van Coevorden F, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol. 2004;11(5):483–90.PubMedCrossRef van Dalen T, Hennipman A, Van Coevorden F, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol. 2004;11(5):483–90.PubMedCrossRef
Metadata
Title
Patterns of Recurrence in Retroperitoneal Liposarcomas: Reflecting Surgical Approach or Tumor Biology?
Author
Dirk C. Strauss, FCS, MMed, FRCS
Publication date
01-07-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 7/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3644-3

Other articles of this Issue 7/2014

Annals of Surgical Oncology 7/2014 Go to the issue